ID: ALA5090955

Max Phase: Preclinical

Molecular Formula: C19H22N6O3S

Molecular Weight: 414.49

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CS(=O)(=O)c1ccc(NC(=O)[C@H]2CC[C@@H](n3cnc4c(N)ncnc43)CC2)cc1

Standard InChI:  InChI=1S/C19H22N6O3S/c1-29(27,28)15-8-4-13(5-9-15)24-19(26)12-2-6-14(7-3-12)25-11-23-16-17(20)21-10-22-18(16)25/h4-5,8-12,14H,2-3,6-7H2,1H3,(H,24,26)(H2,20,21,22)/t12-,14+

Standard InChI Key:  WDOOYTBMQYXIMT-XBXGTLAGSA-N

Associated Targets(Human)

Choline kinase alpha 330 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Choline/ethanolamine kinase 45 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 414.49Molecular Weight (Monoisotopic): 414.1474AlogP: 2.18#Rotatable Bonds: 4
Polar Surface Area: 132.86Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.21CX Basic pKa: 3.77CX LogP: 0.99CX LogD: 0.99
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.67Np Likeness Score: -1.28

References

1. Quartieri F, Nesi M, Avanzi NR, Borghi D, Casale E, Corti E, Cucchi U, Donati D, Fasolini M, Felder ER, Galvani A, Giorgini ML, Lomolino A, Menichincheri M, Orrenius C, Perrera C, Re Depaolini S, Riccardi-Sirtori F, Salsi E, Isacchi A, Gnocchi P..  (2021)  Identification of unprecedented ATP-competitive choline kinase inhibitors.,  51  [PMID:34416377] [10.1016/j.bmcl.2021.128310]

Source